These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24454961)

  • 1. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
    Lagah S; Tan IL; Radhakrishnan P; Hirst RA; Ward JH; O'Callaghan C; Smith SJ; Stevens MF; Grundy RG; Rahman R
    PLoS One; 2014; 9(1):e86187. PubMed ID: 24454961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.
    Muoio D; Berardinelli F; Leone S; Coluzzi E; di Masi A; Doria F; Freccero M; Sgura A; Folini M; Antoccia A
    FEBS J; 2018 Oct; 285(20):3769-3785. PubMed ID: 30095224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
    Gowan SM; Heald R; Stevens MF; Kelland LR
    Mol Pharmacol; 2001 Nov; 60(5):981-8. PubMed ID: 11641426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
    Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
    Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells.
    Berardinelli F; Siteni S; Tanzarella C; Stevens MF; Sgura A; Antoccia A
    DNA Repair (Amst); 2015 Jan; 25():104-15. PubMed ID: 25467559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
    Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
    Amato R; Valenzuela M; Berardinelli F; Salvati E; Maresca C; Leone S; Antoccia A; Sgura A
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.
    Cheng MK; Modi C; Cookson JC; Hutchinson I; Heald RA; McCarroll AJ; Missailidis S; Tanious F; Wilson WD; Mergny JL; Laughton CA; Stevens MF
    J Med Chem; 2008 Feb; 51(4):963-75. PubMed ID: 18247546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.
    Rizzo A; Iachettini S; Zizza P; Cingolani C; Porru M; Artuso S; Stevens M; Hummersone M; Biroccio A; Salvati E; Leonetti C
    J Exp Clin Cancer Res; 2014 Oct; 33(1):81. PubMed ID: 25288403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
    Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
    J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
    Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
    Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat.
    Gavathiotis E; Heald RA; Stevens MF; Searle MS
    J Mol Biol; 2003 Nov; 334(1):25-36. PubMed ID: 14596797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.
    Salvati E; Scarsella M; Porru M; Rizzo A; Iachettini S; Tentori L; Graziani G; D'Incalci M; Stevens MF; Orlandi A; Passeri D; Gilson E; Zupi G; Leonetti C; Biroccio A
    Oncogene; 2010 Nov; 29(47):6280-93. PubMed ID: 20802516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
    Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A
    Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
    Johnson LA; Byrne HM; Willis AE; Laughton CA
    Integr Biol (Camb); 2011 Aug; 3(8):843-9. PubMed ID: 21773618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
    Hu MH; Lin XT; Liu B; Tan JH
    Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.